Generation of Safe and Therapeutically Effective Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Regenerative Medicine

Overview

Journal Hepatol Commun

Specialty Gastroenterology

Date 2018 Feb 7

PMID 29404442

Citations 33

Authors

Kazuo Takayama

Naoki Akita

Natsumi Mimura

Rina Akahira

Yukimasa Taniguchi

Makoto Ikeda

Fuminori Sakurai

Osamu Ohara

Tomohiro Morio

Kiyotoshi Sekiguchi

Hiroyuki Mizuguchi

Affiliations

Soon will be listed here.

Abstract

Hepatocyte-like cells (HLCs) differentiated from human induced pluripotent stem (iPS) cells are expected to be applied for regenerative medicine. In this study, we attempted to generate safe and therapeutically effective human iPS-HLCs for hepatocyte transplantation. First, human iPS-HLCs were generated from a human leukocyte antigen-homozygous donor on the assumption that the allogenic transplantation might be carried out. Highly efficient hepatocyte differentiation was performed under a feeder-free condition using human recombinant laminin 111, laminin 511, and type IV collagen. The percentage of asialoglycoprotein receptor 1-positive cells was greater than 80%, while the percentage of residual undifferentiated cells was approximately 0.003%. In addition, no teratoma formation was observed even at 16 weeks after human iPS-HLC transplantation. Furthermore, harmful genetic somatic single-nucleotide substitutions were not observed during the hepatocyte differentiation process. We also developed a cryopreservation protocol for hepatoblast-like cells without negatively affecting their hepatocyte differentiation potential by programming the freezing temperature. To evaluate the therapeutic potential of human iPS-HLCs, these cells (1 × 10 cells/mouse) were intrasplenically transplanted into acute liver injury mice treated with 3 mL/kg CCl only once and chronic liver injury mice treated with 0.6 mL/kg CCl twice weekly for 8 weeks. By human iPS-HLC transplantation, the survival rate of the acute liver injury mice was significantly increased and the liver fibrosis level of chronic liver injury mice was significantly decreased. : We were able to generate safe and therapeutically effective human iPS-HLCs for hepatocyte transplantation. ( 2017;1:1058-1069).

Citing Articles

Human pluripotent stem cell-derived hepatic progenitors exhibit a partially hypoimmunogenic phenotype and actively inhibit immune responses.

Gantier M, Menoret S, Fourrier A, Delbos F, Nguyen T, Anegon I Front Immunol. 2025; 16:1507317.

PMID: 40070824 PMC: 11893836. DOI: 10.3389/fimmu.2025.1507317.

Interspecies Blastocyst Complementation and the Genesis of Chimeric Solid Human Organs.

Bigliardi E, Shetty A, Low W, Steer C Genes (Basel). 2025; 16(2).

PMID: 40004544 PMC: 11854981. DOI: 10.3390/genes16020215.

Cellular Plasticity in Gut and Liver Regeneration.

Kim M, Park Y, Kim Y, Ko S Gut Liver. 2024; 18(6):949-960.

PMID: 39081200 PMC: 11565004. DOI: 10.5009/gnl240005.

Exploiting in silico modelling to enhance translation of liver cell therapies from bench to bedside.

Ashmore-Harris C, Antonopoulou E, Finney S, Vieira M, Hennessy M, Muench A NPJ Regen Med. 2024; 9(1):19.

PMID: 38724586 PMC: 11081951. DOI: 10.1038/s41536-024-00361-3.

Induced pluripotent stem cell (iPSC) modeling validates reduced GBE1 enzyme activity due to a novel variant, p.Ile694Asn, found in a patient with suspected glycogen storage disease IV.

Naito C, Kosar K, Kishimoto E, Pena L, Huang Y, Hao K Mol Genet Metab Rep. 2024; 39:101069.

PMID: 38516405 PMC: 10955421. DOI: 10.1016/j.ymgmr.2024.101069.

References

Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K . NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood. 2002; 100(9):3175-82. DOI: 10.1182/blood-2001-12-0207. View

Nagamoto Y, Takayama K, Ohashi K, Okamoto R, Sakurai F, Tachibana M . Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure. J Hepatol. 2016; 64(5):1068-1075. DOI: 10.1016/j.jhep.2016.01.004. View

Song Z, Cai J, Liu Y, Zhao D, Yong J, Duo S . Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 2009; 19(11):1233-42. DOI: 10.1038/cr.2009.107. View

Takayama K, Morisaki Y, Kuno S, Nagamoto Y, Harada K, Furukawa N . Prediction of interindividual differences in hepatic functions and drug sensitivity by using human iPS-derived hepatocytes. Proc Natl Acad Sci U S A. 2014; 111(47):16772-7. PMC: 4250156. DOI: 10.1073/pnas.1413481111. View

Si-Tayeb K, Noto F, Nagaoka M, Li J, Battle M, Duris C . Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 2009; 51(1):297-305. PMC: 2946078. DOI: 10.1002/hep.23354. View

Kroigard A, Thomassen M, Laenkholm A, Kruse T, Larsen M . Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data. PLoS One. 2016; 11(3):e0151664. PMC: 4803342. DOI: 10.1371/journal.pone.0151664. View

Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A . An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells. 2012; 31(3):458-66. DOI: 10.1002/stem.1293. View

Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T . Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. 2013; 499(7459):481-4. DOI: 10.1038/nature12271. View

Baxter M, Withey S, Harrison S, Segeritz C, Zhang F, Atkinson-Dell R . Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes. J Hepatol. 2014; 62(3):581-9. PMC: 4334496. DOI: 10.1016/j.jhep.2014.10.016. View

10.

Takayama K, Nagamoto Y, Mimura N, Tashiro K, Sakurai F, Tachibana M . Long-term self-renewal of human ES/iPS-derived hepatoblast-like cells on human laminin 111-coated dishes. Stem Cell Reports. 2013; 1(4):322-35. PMC: 3849256. DOI: 10.1016/j.stemcr.2013.08.006. View

11.

Asgari S, Moslem M, Bagheri-Lankarani K, Pournasr B, Miryounesi M, Baharvand H . Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells. Stem Cell Rev Rep. 2011; 9(4):493-504. DOI: 10.1007/s12015-011-9330-y. View

12.

Liu H, Kim Y, Sharkis S, Marchionni L, Jang Y . In vivo liver regeneration potential of human induced pluripotent stem cells from diverse origins. Sci Transl Med. 2011; 3(82):82ra39. PMC: 3305909. DOI: 10.1126/scitranslmed.3002376. View

13.

Rodin S, Antonsson L, Hovatta O, Tryggvason K . Monolayer culturing and cloning of human pluripotent stem cells on laminin-521-based matrices under xeno-free and chemically defined conditions. Nat Protoc. 2014; 9(10):2354-68. DOI: 10.1038/nprot.2014.159. View

14.

Fox I, Chowdhury J, Kaufman S, Goertzen T, CHOWDHURY N, Warkentin P . Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 1998; 338(20):1422-6. DOI: 10.1056/NEJM199805143382004. View

15.

Cameron K, Tan R, Schmidt-Heck W, Campos G, Lyall M, Wang Y . Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes. Stem Cell Reports. 2015; 5(6):1250-1262. PMC: 4682209. DOI: 10.1016/j.stemcr.2015.10.016. View

16.

Miyazaki T, Futaki S, Suemori H, Taniguchi Y, Yamada M, Kawasaki M . Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells. Nat Commun. 2012; 3:1236. PMC: 3535336. DOI: 10.1038/ncomms2231. View

17.

Taylor R, Turnbull D . Mitochondrial DNA mutations in human disease. Nat Rev Genet. 2005; 6(5):389-402. PMC: 1762815. DOI: 10.1038/nrg1606. View

18.

Kajiwara M, Aoi T, Okita K, Takahashi R, Inoue H, Takayama N . Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012; 109(31):12538-43. PMC: 3411998. DOI: 10.1073/pnas.1209979109. View

19.

Prokhorova T, Harkness L, Frandsen U, Ditzel N, Schroder H, Burns J . Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel. Stem Cells Dev. 2008; 18(1):47-54. DOI: 10.1089/scd.2007.0266. View

20.

Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F . Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996; 334(11):693-9. DOI: 10.1056/NEJM199603143341104. View